Post-market Registry to Assess the Clinical Performance and Safety of the Passeo-18 Lux in Infrainguinal Arteries

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 200 participants.

Also called NCT05175703

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 200 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT05175703
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(anticipated) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT05175703. Allocation not applicable; no masking; primary purpose treatment. Start 2018-03-05 (actual); primary completion 2021-08-31 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Post-market Registry to Assess the Clinical Performance and Safety of the Passeo-18 Lux in Infrainguinal Arteries
Condition
Angioplasty, Balloon
Condition
Disease, Peripheral Artery
Intervention (Device)
Passeo-18 Lux Paclitaxel releasing Balloon Catheter
Lead sponsor
Ajou University School of Medicine (class: other)

Record details

Record id
cardio:ct-nct05175703
Content hash
ca9360f3ffb01f7ff84d5cd676a467fc3ab7882e19621fbc2e3276a4d5e9382e